Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Anterior thalamic nuclei lesions have a greater impact than mammillothalamic tract lesions on the extended hippocampal system.

Perry BAL, Mercer SA, Barnett SC, Lee J, Dalrymple-Alford JC.

Hippocampus. 2017 Nov 18. doi: 10.1002/hipo.22815. [Epub ahead of print]

PMID:
29150979
2.

Neurofilament light as an immune target for pathogenic antibodies.

Puentes F, van der Star BJ, Boomkamp SD, Kipp M, Boon L, Bosca I, Raffel J, Gnanapavan S, van der Valk P, Stephenson J, Barnett SC, Baker D, Amor S.

Immunology. 2017 Dec;152(4):580-588. doi: 10.1111/imm.12797. Epub 2017 Aug 11.

PMID:
28718500
3.

Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.

Cumberworth SL, Barrie JA, Cunningham ME, de Figueiredo DPG, Schultz V, Wilder-Smith AJ, Brennan B, Pena LJ, Freitas de Oliveira França R, Linington C, Barnett SC, Willison HJ, Kohl A, Edgar JM.

Acta Neuropathol Commun. 2017 Jun 23;5(1):50. doi: 10.1186/s40478-017-0450-8.

4.

Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury.

Lindsay SL, Toft A, Griffin J, M M Emraja A, Barnett SC, Riddell JS.

Glia. 2017 Apr;65(4):639-656. doi: 10.1002/glia.23117. Epub 2017 Feb 1.

5.

Effects of Neural Stem Cell and Olfactory Ensheathing Cell Co-transplants on Tissue Remodelling After Transient Focal Cerebral Ischemia in the Adult Rat.

Augestad IL, Nyman AKG, Costa AI, Barnett SC, Sandvig A, Håberg AK, Sandvig I.

Neurochem Res. 2017 Jun;42(6):1599-1609. doi: 10.1007/s11064-016-2098-3. Epub 2017 Jan 24.

PMID:
28120153
6.

Sulfatase-mediated manipulation of the astrocyte-Schwann cell interface.

O'Neill P, Lindsay SL, Pantiru A, Guimond SE, Fagoe N, Verhaagen J, Turnbull JE, Riddell JS, Barnett SC.

Glia. 2017 Jan;65(1):19-33. doi: 10.1002/glia.23047. Epub 2016 Aug 18.

7.

Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?

Lindsay SL, Barnett SC.

Neurochem Int. 2017 Jun;106:101-107. doi: 10.1016/j.neuint.2016.08.001. Epub 2016 Aug 3.

8.

Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.

Allan D, Fairlie-Clarke KJ, Elliott C, Schuh C, Barnett SC, Lassmann H, Linnington C, Jiang HR.

Acta Neuropathol Commun. 2016 Jul 26;4(1):75. doi: 10.1186/s40478-016-0344-1.

9.

Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.

Lindsay SL, Johnstone SA, McGrath MA, Mallinson D, Barnett SC.

Stem Cell Reports. 2016 May 10;6(5):729-742. doi: 10.1016/j.stemcr.2016.03.009. Epub 2016 Apr 21.

10.

The multifaceted role of astrocytes in regulating myelination.

Kıray H, Lindsay SL, Hosseinzadeh S, Barnett SC.

Exp Neurol. 2016 Sep;283(Pt B):541-9. doi: 10.1016/j.expneurol.2016.03.009. Epub 2016 Mar 14. Review.

11.

Spinal Cord Injury Caused by Stab Wounds: Incidence, Natural History, and Relevance for Future Research.

McCaughey EJ, Purcell M, Barnett SC, Allan DB.

J Neurotrauma. 2016 Aug 1;33(15):1416-21. doi: 10.1089/neu.2015.4375. Epub 2016 Mar 18.

PMID:
26825180
12.

Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.

Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L, Miletic H, Sakariassen PØ, Weinstock A, Wagner A, Lindsay SL, Hock AK, Barnett SC, Ruppin E, Mørkve SH, Lund-Johansen M, Chalmers AJ, Bjerkvig R, Niclou SP, Gottlieb E.

Nat Cell Biol. 2015 Dec;17(12):1556-68. doi: 10.1038/ncb3272. Epub 2015 Nov 23.

13.

Time-Lapse Imaging of Glial-Axonal Interactions.

Ioannidou K, Edgar JM, Barnett SC.

Curr Protoc Neurosci. 2015 Jul 1;72:2.23.1-14. doi: 10.1002/0471142301.ns0223s72.

PMID:
26131661
14.

Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.

Lindner M, Thümmler K, Arthur A, Brunner S, Elliott C, McElroy D, Mohan H, Williams A, Edgar JM, Schuh C, Stadelmann C, Barnett SC, Lassmann H, Mücklisch S, Mudaliar M, Schaeren-Wiemers N, Meinl E, Linington C.

Brain. 2015 Jul;138(Pt 7):1875-93. doi: 10.1093/brain/awv102. Epub 2015 Apr 22.

PMID:
25907862
15.

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.

Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C, Barnett SC, Huitinga I, Wekerle H, Hohlfeld R, Lassmann H, Kuhlmann T, Linington C, Meinl E.

Acta Neuropathol Commun. 2014 Dec 11;2:168. doi: 10.1186/s40478-014-0168-9.

16.

Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces.

Johnstone SA, Liley M, Dalby MJ, Barnett SC.

Acta Biomater. 2015 Feb;13:266-76. doi: 10.1016/j.actbio.2014.11.027. Epub 2014 Nov 21.

PMID:
25463488
17.

Astroglial-axonal interactions during early stages of myelination in mixed cultures using in vitro and ex vivo imaging techniques.

Ioannidou K, Anderson KI, Strachan D, Edgar JM, Barnett SC.

BMC Neurosci. 2014 May 2;15:59. doi: 10.1186/1471-2202-15-59.

18.

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

Boomkamp SD, McGrath MA, Houslay MD, Barnett SC.

Br J Pharmacol. 2014 May;171(9):2385-98. doi: 10.1111/bph.12588.

19.

Development of a novel 3D culture system for screening features of a complex implantable device for CNS repair.

Donoghue PS, Sun T, Gadegaard N, Riehle MO, Barnett SC.

Mol Pharm. 2014 Jul 7;11(7):2143-50. doi: 10.1021/mp400526n. Epub 2013 Dec 6.

20.

Schwann cells but not olfactory ensheathing cells inhibit CNS myelination via the secretion of connective tissue growth factor.

Lamond R, Barnett SC.

J Neurosci. 2013 Nov 20;33(47):18686-97. doi: 10.1523/JNEUROSCI.3233-13.2013.

Supplemental Content

Loading ...
Support Center